BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9751810)

  • 21. Structure of amplified DNA, analyzed by pulsed field gradient gel electrophoresis.
    Borst P; Van der Bliek AM; Van der Velde-Koerts T; Hes E
    J Cell Biochem; 1987 Aug; 34(4):247-58. PubMed ID: 3624321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regularities of karyotypic evolution during stepwise amplification of genes determining drug resistance.
    Kopnin BP; Sokova OI; Demidova NS
    Mutat Res; 1992 May; 276(3):163-77. PubMed ID: 1374512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene amplification accompanies low level increases in the activity of dihydrofolate reductase in antifolate-resistant Chinese hamster lung cells containing abnormally banding chromosomes.
    Lewis JA; Biedler JL; Melera PW
    J Cell Biol; 1982 Aug; 94(2):418-24. PubMed ID: 7107708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Only the promoter region of the constitutively expressed normal and amplified human dihydrofolate reductase gene is DNase I hypersensitive and undermethylated.
    Shimada T; Nienhuis AW
    J Biol Chem; 1985 Feb; 260(4):2468-74. PubMed ID: 2982820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moderate-level gene amplification in methotrexate-resistant Chinese hamster ovary cells is accompanied by chromosomal translocations at or near the site of the amplified DHFR gene.
    Flintoff WF; Livingston E; Duff C; Worton RG
    Mol Cell Biol; 1984 Jan; 4(1):69-76. PubMed ID: 6700586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB; McIvor RS
    J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changes in the levels of dihydrofolate reductase mRNA and its gene dosage in 5-fluorouracil-resistant L1210 cells.
    Konishi Y; Kanamaru R; Ishioka C; Ishikawa A; Shibata H; Wakui A; Dei T
    Tohoku J Exp Med; 1990 May; 161(1):33-42. PubMed ID: 2396254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Localization of dihydrofolate reductase amplified genes in Chinese hamster cells resistant to methotrexate].
    Mukhamedkhanova FS; Kuznetsova NN; Nuridzhaniants SS; Abdurkarimov AA
    Genetika; 1987 Sep; 23(9):1588-94. PubMed ID: 3692154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
    Kündig C; Leblanc E; Papadopoulou B; Ouellette M
    Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells.
    Meng X; Qi X; Guo H; Cai M; Li C; Zhu J; Chen F; Guo H; Li J; Zhao Y; Liu P; Jia X; Yu J; Zhang C; Sun W; Yu Y; Jin Y; Bai J; Wang M; Rosales J; Lee KY; Fu S
    J Med Genet; 2015 Feb; 52(2):135-44. PubMed ID: 25537274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased dihydrofolate reductase activity in methotrexate-resistant human promyelocytic-leukaemia (HL-60) cells. Lack of correlation between increased activity and overproduction.
    Dedhar S; Hartley D; Goldie JH
    Biochem J; 1985 Feb; 225(3):609-17. PubMed ID: 3856428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and organization of a stable extrachromosomal element in human cells.
    Esnault C; Lee H; Lai E
    Gene; 1994 Jul; 144(2):205-11. PubMed ID: 7518788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase.
    Bürkle A; Heilbronn R; zur Hausen H
    Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of unstable chromosomal regions containing C-heterochromatin and fragile sites in the integration of amplified dhfr domains.
    Riva P; De Giuli Morghen C; Larizza L
    Somat Cell Mol Genet; 1989 Sep; 15(5):377-85. PubMed ID: 2781413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assignment of two rat dihydrofolate (DHFR) genes to chromosomes 2 and 4.
    Hanson C; Andersson A; Islam MQ; Szpirer J; Szpirer C; Levan G
    Cytogenet Cell Genet; 1990; 53(1):23-5. PubMed ID: 2323224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic changes in methotrexate-resistant mosquito cells.
    Shotkoski FA; Fallon AM
    Arch Insect Biochem Physiol; 1990; 15(2):79-92. PubMed ID: 1724612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-minute chromosomes as megabase cloning vehicles.
    Hahn PJ; Giddings L; Longo J; Lane MJ; Scalzi J; Hozier J
    Genet Anal Tech Appl; 1992 Feb; 9(1):17-25. PubMed ID: 1627362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy.
    Domin BA; Grill SP; Cheng Y
    Cancer Res; 1983 May; 43(5):2155-8. PubMed ID: 6831441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques.
    Hattinger CM; Reverter-Branchat G; Remondini D; Castellani GC; Benini S; Pasello M; Manara MC; Scotlandi K; Picci P; Serra M
    Eur J Cell Biol; 2003 Sep; 82(9):483-93. PubMed ID: 14582536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human dihydrofolate reductase gene is located in chromosome 5 and is unlinked to the related pseudogenes.
    Maurer BJ; Barker PE; Masters JN; Ruddle FH; Attardi G
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1484-8. PubMed ID: 6584893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.